Night Sweats on Mounjaro: Why They Happen and How to Manage Them

Night sweats on Mounjaro are more common than most patients expect. You go to bed feeling fine, then wake at 2 a.m. with damp sheets and a racing heart. It can be unsettling, especially if you have never experienced anything like it before starting tirzepatide.

Although night sweats are not listed as a primary adverse event in the SURMOUNT clinical trial programme, patient reports suggest that up to 10% of people on tirzepatide-based medications experience episodes of excessive sweating during the early weeks of treatment. In most cases, the sweating is temporary and manageable. In a small number of cases, it can signal something that needs medical attention.

This guide explains why night sweats happen on Mounjaro, what the clinical evidence actually says, and what you can do to reduce them. It is written by Dr Emil Gadimali, medical director at CutKilo, a doctor-led Mounjaro weight-loss service based at 86 Harley Street, London.

Night sweats during Mounjaro treatment are usually caused by your body adjusting to rapid metabolic changes. Tirzepatide activates both GLP-1 and GIP receptors, which accelerate your metabolic rate and alter how your body regulates temperature. As your metabolism speeds up and you begin losing fat, your thermoregulatory system can temporarily overcompensate by producing excess heat, particularly during sleep when your body is already working to regulate its core temperature.

Other contributing factors include mild blood sugar dips (especially if you are eating less than usual), dehydration from gastrointestinal side effects such as nausea or diarrhoea, and hormonal shifts triggered by fat loss. For most patients, night sweats peak during the first two to four weeks of treatment or after a dose increase, then gradually settle as the body adapts.

Sweating is not listed as a common or very common adverse event in the MHRA Summary of Product Characteristics (SmPC) for Mounjaro. The SURMOUNT-1 trial, which enrolled over 2,500 participants, did not report sweating as a notable adverse event at any dose level.

However, real-world patient data tells a slightly different story. Community surveys and clinical anecdotes suggest that approximately 5 to 10% of patients notice increased sweating, particularly at night, during the first four to six weeks of treatment or following a dose escalation. The discrepancy between trial data and patient experience likely reflects the fact that night sweats are seldom volunteered in formal adverse-event reporting unless they are severe enough to disrupt daily life.

At CutKilo, we see this pattern regularly in our patient cohort. Most patients describe the sweating as mild to moderate, occurring primarily during the first few weeks at a new dose. Fewer than 1 in 20 patients report sweating severe enough to affect sleep quality over more than a fortnight.

Changes in thermoregulation. Tirzepatide acts on GLP-1 and GIP receptors in the hypothalamus, the brain region responsible for body temperature regulation. As your metabolic rate increases and insulin sensitivity improves, the hypothalamus can temporarily miscalibrate how much heat your body needs to shed. During sleep, when your core temperature naturally dips, this miscalibration can trigger a sweating episode.

Rapid fat metabolism. Fat tissue acts as insulation. When you lose fat quickly, your body’s thermal balance shifts. Additionally, the process of lipolysis (breaking down stored fat for energy) itself generates metabolic heat. Patients in the early weeks of treatment, when weight loss is often fastest, tend to report the most sweating.

Blood sugar fluctuations. Tirzepatide lowers fasting and postprandial glucose levels. If you skip a meal or eat significantly less than usual, your blood sugar may dip low enough to trigger a sympathetic nervous system response. One of the hallmarks of mild hypoglycaemia is sweating, particularly at night. This is more relevant for patients who also take metformin, a sulfonylurea, or insulin alongside Mounjaro.

Dehydration is another important factor. Gastrointestinal side effects such as nausea, vomiting, and diarrhoea are common in the early weeks of Mounjaro treatment and can lead to significant fluid loss. When you are dehydrated, your body struggles to regulate temperature efficiently, which can worsen night sweats. For a detailed guide on protecting yourself, see our article on dehydration on Mounjaro.

Hormonal changes from weight loss. Adipose tissue is metabolically active and produces oestrogen. As you lose fat, circulating oestrogen levels can shift, particularly in women. These hormonal fluctuations can trigger vasomotor symptoms, including hot flushes and night sweats, that mimic perimenopausal symptoms even in younger women.

In most cases, night sweats on Mounjaro are benign and self-limiting. However, certain patterns warrant a conversation with your prescribing doctor.

Signs that need medical review:

• Night sweats accompanied by a rapid heartbeat, confusion, trembling, or feeling faint, which may indicate hypoglycaemia
• Sweating that persists beyond six to eight weeks at a stable dose without improvement
• New-onset fever, unexplained weight loss beyond what is expected from treatment, or swollen lymph nodes
• Sweating that occurs alongside chest pain, shortness of breath, or significant anxiety

Persistent or severe night sweats can occasionally be a sign of an underlying condition unrelated to Mounjaro, including thyroid dysfunction, infection, or, rarely, haematological conditions. Your doctor can rule these out with a simple blood panel that includes thyroid function, full blood count, fasting glucose, and inflammatory markers such as CRP.

There are several practical strategies that can reduce the frequency and severity of night sweats during treatment.

Stay well hydrated. Aim for at least 2 litres of water daily, and increase your intake if you are experiencing nausea, vomiting, or diarrhoea. Sipping water throughout the evening, rather than drinking a large amount just before bed, helps your body maintain fluid balance overnight.

Optimise your sleep environment. Keep your bedroom cool, ideally between 16 and 18 degrees Celsius. Use breathable, moisture-wicking bedding and sleepwear made from natural fibres such as cotton or bamboo. A fan or open window can help air circulate and prevent heat build-up.

Eat a balanced evening meal. Avoid going to bed on an empty stomach, as this increases the risk of a nocturnal blood sugar dip. A small, protein-forward snack before bed, such as a handful of nuts, a small portion of Greek yoghurt, or a slice of cheese, can help stabilise your glucose levels overnight.

Time your injection carefully. Some patients find that injecting Mounjaro in the morning rather than the evening reduces night-time side effects, including sweating. If you currently inject in the evening and are experiencing significant night sweats, discuss switching your injection timing with your prescribing doctor.

Monitor your blood sugar. If you take Mounjaro alongside other glucose-lowering medications, consider monitoring your blood sugar before bed and during the night if you wake with sweats. A reading below 4 mmol/L suggests hypoglycaemia and should be discussed with your doctor, who may adjust your other medications.

For the majority of patients, yes. Night sweats on Mounjaro typically follow a predictable pattern. They are most noticeable during the first two to four weeks of treatment, or in the first week or two after a dose increase. As your body adapts to the new metabolic state, the sweating usually diminishes.

Most patients at CutKilo who report night sweats find that the episodes reduce significantly within four to six weeks at a stable dose. A smaller number of patients experience intermittent sweating throughout their treatment, particularly during periods of rapid weight loss. In these cases, the sweating is rarely severe enough to require any change to the treatment plan.

If night sweats are significantly disrupting your sleep for more than six weeks at the same dose, your prescribing doctor may consider a temporary dose reduction, a change in injection timing, or a review of any concurrent medications that could be contributing.

Is sweating a listed side effect of Mounjaro? Sweating is not listed as a common or very common side effect in the MHRA Summary of Product Characteristics for tirzepatide. However, real-world reports suggest that up to 10% of patients experience some degree of increased sweating, particularly at night, during the early weeks of treatment.

Can Mounjaro cause hot flushes? Yes. Some patients, particularly women, report hot flushes during Mounjaro treatment. These are likely caused by a combination of hormonal shifts from fat loss (adipose tissue produces oestrogen) and changes in hypothalamic thermoregulation triggered by GLP-1 and GIP receptor activation.

Should I stop Mounjaro if I get night sweats? In most cases, no. Night sweats are usually a temporary side effect that resolves within a few weeks. However, if sweating is accompanied by symptoms such as confusion, trembling, rapid heartbeat, or feeling faint, contact your prescribing doctor promptly as these may indicate hypoglycaemia.

Will a lower dose of Mounjaro reduce night sweats? It may. Some patients find that night sweats are more prominent at higher doses. If sweating is persistent and bothersome, your doctor may recommend staying at your current dose for longer before escalating, or temporarily stepping back to a lower dose.

Do night sweats mean Mounjaro is working? Not directly. Night sweats are a side effect, not a marker of efficacy. However, the metabolic changes that cause sweating (increased metabolic rate, active fat breakdown, improved insulin sensitivity) are the same processes that drive weight loss on tirzepatide. So while sweating itself does not confirm the medication is working, the underlying metabolic activity often does.

Night sweats on Mounjaro are a common, underreported side effect that usually resolves within the first four to six weeks of treatment. They are driven by a combination of metabolic acceleration, thermoregulatory adjustment, blood sugar fluctuations, and hormonal changes from fat loss. For the vast majority of patients, simple measures such as staying hydrated, keeping the bedroom cool, and eating a balanced evening meal are enough to manage the sweating comfortably.

If night sweats are severe, persistent, or accompanied by warning signs such as confusion, trembling, or fever, speak with your prescribing doctor. In rare cases, the sweating may point to an underlying condition that needs investigation.